Overview
Klaus Okkenhaug practices in Cambridge, United Kingdom. Mr. Okkenhaug is rated as a Distinguished expert by MediFind in the treatment of Activated PI3K Delta Syndrome (APDS). His top areas of expertise are Activated PI3K Delta Syndrome (APDS), Lymphoid Hyperplasia, Lymphofollicular Hyperplasia, and Primary Immunodeficiency (PID).
His clinical research consists of co-authoring 84 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Activated PI3K Delta Syndrome (APDS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Activated PI3K Delta Syndrome (APDS)Mr. Okkenhaug isDistinguished. Learn about Activated PI3K Delta Syndrome (APDS).
- Advanced
- Lymphoid HyperplasiaMr. Okkenhaug isAdvanced. Learn about Lymphoid Hyperplasia.
- Experienced
- Bronchiolitis ObliteransMr. Okkenhaug isExperienced. Learn about Bronchiolitis Obliterans.
- Chronic B-Cell Leukemia (CBCL)Mr. Okkenhaug isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Okkenhaug isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- LeukemiaMr. Okkenhaug isExperienced. Learn about Leukemia.
- Localized SclerodermaMr. Okkenhaug isExperienced. Learn about Localized Scleroderma.
- Lymphofollicular HyperplasiaMr. Okkenhaug isExperienced. Learn about Lymphofollicular Hyperplasia.